| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |